Table 1 CD22 immunohistochemical staining
From: CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
Location of CD22 | Number | Percent |
|---|---|---|
Cell membrane and cytoplasmic positive | 46 | 52.87 |
Cell membrane positive | 24 | 27.59 |
Cell membrane negative | 17 | 19.54 |